Progenics Pharmaceuticals

genengnews.com: Genetic Engineering genengnews.com

AP Pharma names new president and CEO

pharmaceutical-business-review.com     Jul 9, 2008   23 related          

AP Pharma has appointed Ronald Prentki as its new president, CEO and a member of the company's board of directors. Mr Prentki succeeds Gregory Turnbull, who will remain a company director, a member of the board's executive...                    

comments

                   

InvestSource Inc.: IVI Communications Consummates Loan and Security Agreement

tmcnet.com     Jul 7, 2008   1 related          

Stocks in the News: IVI Communications, Inc. ("IVI") (OTCBB: IVCM), Titan Global Holdings, Inc. (Pink Sheets: TTGL), Wyeth Pharmaceuticals (NYSE: WYE), Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX), Harsco Corporation (NYSE:...                    

comments

                   

Wyeth Pharmaceuticals, Progenics Drug Relistor Gets European Union Approval

pharmiweb.co.uk     Jul 7, 2008   12 related          

Released : Monday, July 07, 2008 1:28 AM July 7, 2008 (FinancialWire) Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE) and Progenics Pharmaceuticals Inc. (NASDAQ: PGNX) have received marketing approval from the European...                    

comments

                   

Wyeth and Progenics Receive Approval From European Commission for RELISTOR for Opioid-Induced...

redorbit.com     Jul 3, 2008   7 related          

Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide)...                    

comments

                   

Wyeth, Progenics get European constipation drug OK

ibtimes.com     Jul 3, 2008   16 related          

NEW YORK (AP) - Drug developers Wyeth and Progenics Pharmaceuticals Inc. said Thursday European regulators approved Relistor as a treatment for constipation related to pain drugs taken by terminally ill patients. The injectable...                    

comments

Wyeth Earnings Call scheduled for Wed, July 23 (CCBN)

yahoo.com     Jul 1, 2008   1 related          

Wyeth Earnings Conference Call (Q2 2008) Scheduled to start Wed, Jul 23, 2008, 8:00 am Eastern After the event has finished, the audio will be available from this page until Fri, Jul 24, 2009 Wyeth engages in the discovery,...                    

comments

                   

Solid Tumor Space Companies Examined in Wall Street Transcript Biotechnology Report (Wall Street...

yahoo.com     Jun 27, 2008   3 related          

67 WALL STREET, New York - The Wall Street Transcript has just published its Biotechnology issue, a report offering a timely review of the sector to serious investors and industry executives. The full issue is available by...                    

comments

TradingMarkets Monday Stock Movers: AVNX, CHRD, PGNX, SCUR, WNR (TradingMarkets.com)

yahoo.com     Jun 2, 2008          

With the markets opening lower, there are a number of weak stocks that had been drifting higher in recent days, becoming more and more overbought in the process. Here are 5 stocks with low Short Term PowerRatings that may be in the...                    

comments

                   

Making Sh*t Happen: Methylnaltrexone

pallimed.org     May 30, 2008   1 related          

Methylnatrexone has hit the big time with a very timely publication of a industry funded double-blinded RCT in the New England Journal of Medicine. We have touched on MNTX a few times here at Pallimed before.This new study does not...                    

comments

                   

New drug may ease severe constipation

msn.com     May 29, 2008   9 related          

An experimental once-a-day pill offered relief to nearly half the people with severe, long-term constipation, researchers reported on Wednesday. ... Once-a-day pill helps people with long-term condition, researchers report BOSTON - The drug prucalopride, which...                    

comments